BR112022024128A2 - Composição de microbiota vaginal, e, método para tratar uma infecção - Google Patents

Composição de microbiota vaginal, e, método para tratar uma infecção

Info

Publication number
BR112022024128A2
BR112022024128A2 BR112022024128A BR112022024128A BR112022024128A2 BR 112022024128 A2 BR112022024128 A2 BR 112022024128A2 BR 112022024128 A BR112022024128 A BR 112022024128A BR 112022024128 A BR112022024128 A BR 112022024128A BR 112022024128 A2 BR112022024128 A2 BR 112022024128A2
Authority
BR
Brazil
Prior art keywords
composition
vaginal microbiota
infection
treat
lactobacillus
Prior art date
Application number
BR112022024128A
Other languages
English (en)
Inventor
M Walsh Dana
Hau Heidi
Strandberg Kristi
F Blount Kenneth
a jones Lee
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of BR112022024128A2 publication Critical patent/BR112022024128A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSIÇÃO DE MICROBIOTA VAGINAL, E, USO DE UMA COMPOSIÇÃO. Trata-se de composições e métodos para tratar pacientes. Uma composição exemplificativa pode incluir uma composição de microbiota vaginal. A composição de microbiota vaginal pode incluir uma mistura de bactérias. A mistura de bactérias pode incluir Lactobacillus crispatus, Lactobacillus gasseri, Lactobacillus jensenii e Lactobacillus rhamnosus.
BR112022024128A 2020-06-01 2021-06-01 Composição de microbiota vaginal, e, método para tratar uma infecção BR112022024128A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063033008P 2020-06-01 2020-06-01
PCT/US2021/035245 WO2021247571A1 (en) 2020-06-01 2021-06-01 Vaginal microbiota compositions

Publications (1)

Publication Number Publication Date
BR112022024128A2 true BR112022024128A2 (pt) 2022-12-27

Family

ID=76601828

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022024128A BR112022024128A2 (pt) 2020-06-01 2021-06-01 Composição de microbiota vaginal, e, método para tratar uma infecção

Country Status (10)

Country Link
US (1) US20230201281A1 (pt)
EP (1) EP4157298A1 (pt)
JP (1) JP2023527876A (pt)
KR (1) KR20230018389A (pt)
CN (1) CN115768451A (pt)
AU (1) AU2021284269A1 (pt)
BR (1) BR112022024128A2 (pt)
CA (1) CA3179613A1 (pt)
MX (1) MX2022014160A (pt)
WO (1) WO2021247571A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3294073T3 (da) 2015-05-11 2022-11-14 Mybiotics Pharma Ltd Systemer og fremgangsmåder til dyrkning af en biofilm af probiotiske bakterier på faste partikler til kolonisering af bakterier i tarmen
JP7198087B2 (ja) 2016-05-25 2022-12-28 マイバイオティクス ファーマ リミテッド 微生物叢療法のための組成物及び方法
WO2024072421A1 (en) * 2022-09-30 2024-04-04 Bonafide Health, Llc Probiotic and folic acid compositions and methods of using
CN117535207A (zh) * 2024-01-04 2024-02-09 四川厌氧生物科技有限责任公司 一种格氏乳杆菌及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3564357T3 (pl) 2010-02-01 2022-08-08 Rebiotix, Inc. Bakterioterapia zapalenia jelita grubego z clostridium difficile
EP2428214A1 (en) * 2010-09-14 2012-03-14 HSO Health Care GmbH Compositions for the vaginal and oral administration of lactobacillus and uses thereof
EP4234011A3 (en) 2013-06-05 2023-09-20 Rebiotix, Inc. Microbiota restoration therapy (mrt), compositions and methods of manufacture
BR112016026654A2 (pt) * 2014-05-16 2017-08-15 Pizeta Group Srl Composições contendo ácido bórico e uma mistura de lactobacillus
CA2986915C (en) 2015-06-09 2023-09-19 Rebiotix, Inc. Microbiota restoration therapy (mrt) compositions and methods of manufacture
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
CA2989977A1 (en) * 2015-06-29 2017-01-05 Ferring B.V. Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis
WO2018013583A2 (en) * 2016-07-11 2018-01-18 The Brigham And Women's Hospital, Inc. Medicinal vaginal lactobacillus cocktail

Also Published As

Publication number Publication date
JP2023527876A (ja) 2023-06-30
MX2022014160A (es) 2022-11-30
CN115768451A (zh) 2023-03-07
WO2021247571A1 (en) 2021-12-09
CA3179613A1 (en) 2021-12-09
KR20230018389A (ko) 2023-02-07
AU2021284269A1 (en) 2023-01-05
US20230201281A1 (en) 2023-06-29
EP4157298A1 (en) 2023-04-05

Similar Documents

Publication Publication Date Title
BR112022024128A2 (pt) Composição de microbiota vaginal, e, método para tratar uma infecção
Callewaert et al. Skin microbiome transplantation and manipulation: Current state of the art
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
JP2023133467A (ja) プロバイオティクスに基づいた組成物及びその使用
CO2018010954A2 (es) Nuevo uso médico de probioticos
RU2728161C2 (ru) Средство для профилактического и/или терапевтического лечения вызванных патогенными бактериями инфекций и/или воспалений (варианты)
EA201490512A1 (ru) Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека
BR112022004569A2 (pt) Cepas bacterianas, suas composições e seu uso para o tratamento de distúrbios gastrointestinais
RU2014145534A (ru) Пробиотические бактерии
AR035761A1 (es) Bacterias de acido lactico como agentes para tratar y prevenir la alergia
WO2019066599A3 (ko) 신규 유산균 및 이의 용도
CO6270334A2 (es) Microorganismos de la leche de mamiferos, composiciones que los contienen y su uso para el tratamiento de la mastitis
Bernard et al. Corynebacterium
Goyal et al. Human soft tissue infection by the emerging pathogen Shewanella algae
ATE480247T1 (de) Immunstimulierendes mittel enthaltend eine biomasse von methanotrophem bakterium
BR112019014500A2 (pt) Composição bioquímica probiótica, método de produção de couro, método de redução de sulfito de sódio na produção de produtos de couro e uso de uma composição bioquímica probiótica
MX2021012041A (es) Metodos para promover la diferenciacion de celulas epiteliales timicas y progenitores de celulas epiteliales timicas de celulas madre pluripotentes, celulas resultantes y usos de estas.
López-Salas et al. Virulence and antibiotic resistance of Enterococcus faecalis clinical isolates recovered from three states of Mexico. Detection of linezolid resistance
DE602004022689D1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
MX2021010665A (es) Metodos de tratamiento de amiloidosis al.
Ibnoulkhatib et al. Post-traumatic bone and/or joint limb infections due to Clostridium spp.
MX2022008666A (es) Composicion probiotica para su uso como antioxidante.
BR112023000712A2 (pt) Mistura de micro-organismos, composição, uso de uma mistura ou de uma composição, e, cepa
BR112022004032A2 (pt) Composições probióticas mixotróficas e usos das mesmas no tratamento de distensão abdominal
RS57471B1 (sr) Nova probiotička starter kultura za humanu i animalnu primenu